Han Zhu
- Stanford University · Internal Medicine (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #12,262
- R01 Holder
- Early Career
- Mentor
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15438144Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2026
Linked Award Amount
$1.6M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#12,262
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Han Zhu as a PI. Multi-PI records show the full award amount for context.
- 5R01HL177581-02R01Contact PIA Targeted Approach to Treat Immunotherapy-Induced Myocarditis with CXCR3 BlockadeStanford University · Internal Medicine (NIH department code)$744.8Kaward amount
- 5R01HL174432-03R01Contact PIInvestigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR PhenotypingStanford University · Internal Medicine (NIH department code)$722.1Kaward amount
- 5K08HL161405-05K08Contact PIIdentification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced MyocarditisStanford University · Internal Medicine (NIH department code)$166.3Kaward amount
Award organization
Organizations that administered FY2026 awards listing Han Zhu as a PI.
FY2026 award administered by Stanford University (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardStanford University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #7808
- 2025R01 Grant Holder